"There are many approaches to curing the disease, such as strong drugs or destruction of troubled cells in the brain, but use of embryonic stem cells is seen as an ideal and fundamental therapy for the disease," he said.
A small group of people with Parkinson's disease had been pleading for months with the biotechnology company Amgen: Let them resume taking an experimental drug that the patients said had helped them but which the company said was ineffective and possibly dangerous.
The government said Switzerland should not lose its edge in pharmacology and bio-technology by banning stem cell research, which
